Fereydoun Firouz

Fereydoun Firouz, a seasoned leader in the biopharma industry, has joined our board of Directors. Fereydoun brings a wealth of experience, having previously held influential roles in various organizations. His career includes serving as the past Chairman and CEO of Stallergenes Greer, a leading global biopharma company. Before that, he co-founded and served as the managing partner of Gurnet Point Capital, a key investor in life sciences companies, as well as being the managing director at B-Flexion (USA), part of the Swiss-based private, entrepreneurial investment firm.

With over 25 years of dedicated service at the biopharma giant Merck Serono, Fereydoun rose through the ranks to ultimately lead the US business EMD Serono as its President and CEO. His multifaceted background, spanning leadership, investment, and strategic roles, underscores his commitment to advancing innovation and excellence in the life sciences industry.

Fereydoun is a Senior Fellow with the Harvard Advanced Leadership Initiative and serves on the Belfer Center International Council. He serves on the presidential advisory council at Berklee College of Music and the John F. Kennedy Library Foundation. Fereydoun’s diverse interests also extend to the creative realm, where he produced short films and documentaries focusing on Persian art and culture.

Notably, Fereydoun’s past experiences include serving as a Red Cross delegate in Afghanistan during the Soviet-Afghan war and holding an officer position in the Swiss Army.